Myocardial Injury in Multiple Myeloma Patients With Preserved Left Ventricular Ejection Fraction: Noninvasive Left Ventricular Pressure-Strain Myocardial Work

Zhiyue Liu; Li Zhang; Mei Liu; Fang Wang; Yanqiu Xiong; Zhuoqin Tang; Qian Li; Qiuchen Lu; Shichu Liang; Ting Niu; He Huang

doi:10.3389/fcvm.2021.782580

Myocardial Injury in Multiple Myeloma Patients With Preserved Left Ventricular Ejection Fraction: Noninvasive Left Ventricular Pressure-Strain Myocardial Work

Front Cardiovasc Med. 2022 Jan 20:8:782580. doi: 10.3389/fcvm.2021.782580. eCollection 2021.

Authors

Zhiyue Liu¹, Li Zhang², Mei Liu¹, Fang Wang¹, Yanqiu Xiong², Zhuoqin Tang¹, Qian Li¹, Qiuchen Lu³, Shichu Liang¹, Ting Niu², He Huang¹

Affiliations

¹ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
³ Department of Ultrasound, Mianyang Central Hospital, Mianyang, China.

Abstract

Introduction: Over one-half of patients with multiple myeloma (MM) die of heart failure or arrhythmia. Left ventricular ejection fraction (LVEF) is used to describe left ventricular systolic function. However, depressed LVEF means advanced stage of left ventricular dysfunction in patients with MM. Left ventricular pressure-strain-derived myocardial work (LVMW) is a novel and noninvasive method for evaluating LV function related to LV dynamic pressure load. MW is assessed by LV MW index (LVMWI), constructive work, wasted work, and LV MW efficiency (LVMWE). In this study, we aimed to investigate the value of LVMW in cardiac function assessment and clinical prognosis of MM patients with preserved LVEF.

Methods: A total of 72 subjects, including 40 untreated MM patients with preserved EF (including the thick wall and normal wall groups) and 32 non-MM patients, were enrolled in this study. Laboratory data and clinical history of all the patients were collected. All the patients underwent comprehensive echocardiographic examinations and then LVMWI and LVMWE were calculated. Moreover, cardiac adverse events (CAEs) were observed in MM patients treated with bortezomib-based therapy after 6 months and the prognostic value of MW was assessed.

Results: (1) LV myocardial global work index (GWI), myocardial global work efficiency (GWE), and global longitudinal strain (GLS) were lower in the thick wall group of patients with MM compared with the normal wall group and controls. Cardiac segmental analysis of LVMWI in patients with MM showed an apical sparing pattern; (2) The area under the curve (AUC) of GWE for judging the disease severity based on the Revised International Staging System (R-ISS) was 0.835 (95% CI: 0.684-0.933, p < 0.05); (3) GWE, Lg_dFLC, and arrhythmia were independent risk factors of CAEs. The AUC of GWE for predicting CAEs in MM patients treated with bortezomib-based therapy for 6 months follow-up was 0.896 (95% CI: 0.758-0.970, p < 0.05).

Conclusion: MM Patients with preserved EF had subclinical LV systolic dysfunction, which was worse in the thick wall group. LVMWI was presented as "apical sparing" in patients with MM. A lower LVGWE may have a predictive value for CAEs in patients with MM after 6 months of follow-up.

Keywords: cardiac adverse events; cardiac injury; left ventricular pressure-strain-derived myocardial work; multiple myeloma; preserved left ventricular ejection fraction.